Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

233 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Reliability and safety of intravitreal Ozurdex injections. The ZERO study].
Schmitz K, Maier M, Clemens CR, Höhn F, Wachtlin J, Lehmann F, Bertelmann T, Rüdiger K, Horn M, Bezatis A, Spital G, Meyer CH; German Retinal Vein Occlusion Group. Schmitz K, et al. Ophthalmologe. 2014 Jan;111(1):44-52. doi: 10.1007/s00347-012-2737-2. Ophthalmologe. 2014. PMID: 23559321 German.
[Progressive scotoma with perception of photopsia].
Bemme S, Pleyer U, Salehi N, Naxer S, Callizo J, Hoerauf H, Feltgen N. Bemme S, et al. Among authors: feltgen n. Ophthalmologe. 2016 Jan;113(1):66-70. doi: 10.1007/s00347-015-0012-z. Ophthalmologe. 2016. PMID: 25930180 German.
Clinical Efficacy and Safety of Ranibizumab Versus Dexamethasone for Central Retinal Vein Occlusion (COMRADE C): A European Label Study.
Hoerauf H, Feltgen N, Weiss C, Paulus EM, Schmitz-Valckenberg S, Pielen A, Puri P, Berk H, Eter N, Wiedemann P, Lang GE, Rehak M, Wolf A, Bertelmann T, Hattenbach LO; COMRADE-C Study Group. Hoerauf H, et al. Among authors: feltgen n. Am J Ophthalmol. 2016 Sep;169:258-267. doi: 10.1016/j.ajo.2016.04.020. Epub 2016 May 7. Am J Ophthalmol. 2016. PMID: 27163237 Clinical Trial.
[Arch-shaped retinal appearance of a previously healthy women].
Khattab M, Feltgen N, Bemme S, Hoerauf H, Storch M. Khattab M, et al. Among authors: feltgen n. Ophthalmologe. 2017 Jul;114(7):656-660. doi: 10.1007/s00347-016-0417-3. Ophthalmologe. 2017. PMID: 27966033 German. No abstract available.
Efficacy and safety of a fixed bimonthly ranibizumab treatment regimen in eyes with neovascular age-related macular degeneration: results from the RABIMO trial.
Feltgen N, Bertelmann T, Bretag M, Pfeiffer S, Hilgers R, Callizo J, Goldammer L, Bemme S, Hoerauf H. Feltgen N, et al. Graefes Arch Clin Exp Ophthalmol. 2017 May;255(5):923-934. doi: 10.1007/s00417-017-3589-x. Epub 2017 Jan 19. Graefes Arch Clin Exp Ophthalmol. 2017. PMID: 28102456 Clinical Trial.
Head-to-head comparison of ranibizumab PRN versus single-dose dexamethasone for branch retinal vein occlusion (COMRADE-B).
Hattenbach LO, Feltgen N, Bertelmann T, Schmitz-Valckenberg S, Berk H, Eter N, Lang GE, Rehak M, Taylor SR, Wolf A, Weiss C, Paulus EM, Pielen A, Hoerauf H; COMRADE-B Study Group. Hattenbach LO, et al. Among authors: feltgen n. Acta Ophthalmol. 2018 Feb;96(1):e10-e18. doi: 10.1111/aos.13381. Epub 2017 Mar 2. Acta Ophthalmol. 2018. PMID: 28251811 Free article. Clinical Trial.
233 results